Skip to main content
SpringerLink
Log in

VOICE trial: low adherence for HIV prophylaxis in African women

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. VOICE = Vaginal and Oral Interventions to Control the Epidemic. This trial was funded by the US National Institutes of Health (NIH).

References

  1. Marrazzo JM, et al. Tenofovir-Based Preexposure Prophylaxis for HIV Infection among African Women. New England Journal of Medicine 372: 509-18, No. 6, 5 Feb 2015. Available from: URL: http://www.nejm.org/doi/full/10.1056/NEJMoa1402269.

    Article  CAS  PubMed  Google Scholar 

  2. Saag MS. Preventing HIV in Women - Still Trying to Find Their VOICE. New England Journal of Medicine 372: 564-6, No. 6, 5 Feb 2015. Available from: URL: http://www.nejm.org/doi/full/10.1056/NEJMe1415750.

    Article  PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

VOICE trial: low adherence for HIV prophylaxis in African women. PharmacoEcon Outcomes News 722, 29 (2015). https://doi.org/10.1007/s40274-015-1935-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-015-1935-y

Search

Navigation